RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCI SCIE SCOPUS

      Hematopoietic Stem Cell Transplantation in Children with Leukemia: A Single Institution Experience with Respect to Donors

      한글로보기

      https://www.riss.kr/link?id=A104750322

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Aim of this study was to compare the outcomes of transplantation by donor source and to help select the best alternative donor in children with leukemia. Donor sources included matched related donor (MRD, n = 35), allele-matched unrelated donor (M-UD,...

      Aim of this study was to compare the outcomes of transplantation by donor source and to help select the best alternative donor in children with leukemia. Donor sources included matched related donor (MRD, n = 35), allele-matched unrelated donor (M-UD, n = 10) or -mismatched (MM)-UD (n = 13) or unrelated umbilical cord blood (UCB, n = 11). UCB group had a significantly higher incidence of grade II-IV acute graft versus host disease (MRD, 11.8%; M-UD, 30.0%; MM-UD, 15.4%, UCB, 54.4%, P = 0.004) but there was no difference in incidence of chronic graft versus host disease between 4 groups. The 5-yr leukemia-free survival (LFS) was 76.7%, 60.0%, 69.2%, and 45.5%, respectively (P = 0.128). MRD group showed higher LFS rate than UCB group (P = 0.022). However,LFS of M-UD and MM-UD together (65.2%) was not different from that of MRD group (76.7%, P = 0.325), or from that of UCB (45.5%, P = 0.190). The relapse incidence at 5 yr was 17.1%, 20.0%, 15.4%, and 0%, respectively (P = 0.460). The 100-day treatmentrelated mortality was 2.9%, 20.0%, 7.7%, and 36.4%, respectively (P = 0.011). Despite the limitations of small number of patients, unrelated donor transplants including even allele-mismatched ones, seem to be as effective in children with leukemia lacking suitable relative donors. Also, UCB transplant may serve as another possible option in urgent transplants.

      더보기

      참고문헌 (Reference)

      1 Grewal SS, "Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood" 101 : 4233-4244, 2003

      2 이재희, "Unrelated Hematopoietic Stem Cell Transplantation for Children with Acute Leukemia: Experience at a Single Institution" 대한의학회 24 (24): 904-909, 2009

      3 Wagner JE, "Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival" 100 : 1611-1618, 2002

      4 Barker JN, "Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy" 105 : 1343-1347, 2005

      5 Morishima Y, "The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors" 99 : 4200-4206, 2002

      6 Petersdorf EW, "The biological significance of HLA-DP gene variation in haematopoietic cell transplantation" 112 : 988-994, 2001

      7 Takahashi S, "Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies" 104 : 3813-3820, 2004

      8 Al-Kasim FA, "Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants" 116 : 483-490, 2002

      9 Rocha V, "Searching for alternative hematopoietic stem cell donors for pediatric patients" 41 : 207-214, 2008

      10 Dalle JH, "Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLAmatched bone marrow" 33 : 605-611, 2004

      1 Grewal SS, "Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood" 101 : 4233-4244, 2003

      2 이재희, "Unrelated Hematopoietic Stem Cell Transplantation for Children with Acute Leukemia: Experience at a Single Institution" 대한의학회 24 (24): 904-909, 2009

      3 Wagner JE, "Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival" 100 : 1611-1618, 2002

      4 Barker JN, "Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy" 105 : 1343-1347, 2005

      5 Morishima Y, "The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors" 99 : 4200-4206, 2002

      6 Petersdorf EW, "The biological significance of HLA-DP gene variation in haematopoietic cell transplantation" 112 : 988-994, 2001

      7 Takahashi S, "Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies" 104 : 3813-3820, 2004

      8 Al-Kasim FA, "Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants" 116 : 483-490, 2002

      9 Rocha V, "Searching for alternative hematopoietic stem cell donors for pediatric patients" 41 : 207-214, 2008

      10 Dalle JH, "Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLAmatched bone marrow" 33 : 605-611, 2004

      11 Parham P, "Population biology of antigen presentation by MHC class I molecules" 272 : 67-74, 1996

      12 Rocha V, "Pediatric related and unrelated cord blood transplantation for malignant diseases" 44 : 653-659, 2009

      13 Eapen M, "Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study" 369 : 1947-1954, 2007

      14 Laughlin MJ, "Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia" 351 : 2265-2275, 2004

      15 Bray RA, "National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants" 14 : 45-53, 2008

      16 Kamani N, "National marrow Donor Program. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants" 14 : 1-6, 2008

      17 Flomenberg N, "Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome" 104 : 1923-1930, 2004

      18 Lee SJ, "High resolution donor–recipient HLA matching contributes to the success of unrelated donor marrow transplantation" 110 : 4576-4583, 2007

      19 Smith AR, "Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors" 15 : 1086-1093, 2009

      20 Rocha V, "Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources" 342 : 1846-1854, 2000

      21 Decorte R, "Forensic medicine and the polymerase chain reaction technique" 30 : 625-633, 1993

      22 Rocha V, "Eurocord and European Blood and Marrow Transplant Group. Clinical use of umbilical cord blood hematopoietic stem cells" 12 : 34-41, 2006

      23 Michel G, "Eurocord Group. Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis" 102 : 4290-4297, 2003

      24 Gluckman E, "Eurocord Group. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice" 32 : 397-407, 2004

      25 Scrucca L, "Competing risk analysis using R: an easy guide for clinicians" 40 : 381-387, 2007

      26 Rocha V, "Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia" 97 : 2962-2971, 2001

      27 Kollman C, "Assessment of optimal size and composition of the US National Registry of hematopoietic stem cell donors" 78 : 89-95, 2004

      28 Rocha V, "Acute Leukemia Working Party of European Blood and marrow Transplant Group, Eurocord-Netcord Registry. Transplants of umbilical cord blood or bone marrow from unrelated donors in adult with acute leukaemia" 351 : 2276-2285, 2004

      29 Hwang WY, "A meta-analysis of unrelated donor umbilical cord blood transplantation versus unrelated donor bone marrow transplantation in adult and pediatric patients" 13 : 444-453, 2007

      30 Przepiorka D, "1994 Consensus Conference on Acute GVHD Grading" 15 : 825-828, 1995

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 SCI 등재 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.48 0.37 1.06
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.85 0.75 0.691 0.11
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼